Technical Analysis for 0IDA - Dynavax Technologies Corp.

Grade Last Price % Change Price Change
F 11.29 -0.66% -0.08
0IDA closed down 0.66 percent on Tuesday, April 30, 2024, on 44 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Earnings Movers Other 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -0.66%
Pocket Pivot Bullish Swing Setup -0.66%
Narrow Range Bar Range Contraction -0.66%
Gapped Up Strength -0.66%
Oversold Stochastic Weakness -0.66%
New Downtrend Bearish 1.02%
Hammer Candlestick Bullish 1.02%
Lizard Bullish Bullish Day Trade Setup 1.02%

   Recent Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Dynavax Technologies Corp. Description

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.


Classification

Keywords: Biotechnology Life Sciences Biopharmaceutical Infection Vaccine Pharmaceutical Industry In India Stage Biopharmaceutical

Is 0IDA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.15
52 Week Low 9.55
Average Volume 823
200-Day Moving Average 13.45
50-Day Moving Average 12.19
20-Day Moving Average 11.71
10-Day Moving Average 11.47
Average True Range 0.22
RSI (14) 39.02
ADX 25.21
+DI 28.18
-DI 46.10
Chandelier Exit (Long, 3 ATRs) 11.84
Chandelier Exit (Short, 3 ATRs) 11.77
Upper Bollinger Bands 12.42
Lower Bollinger Band 11.01
Percent B (%b) 0.19
BandWidth 12.00
MACD Line -0.27
MACD Signal Line -0.25
MACD Histogram -0.0215
Fundamentals Value
Market Cap 7.07 Million
Num Shares 62.7 Million
EPS 0.75
Price-to-Earnings (P/E) Ratio 14.99
Price-to-Sales 0.01
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.45
Resistance 3 (R3) 11.46 11.41 11.42
Resistance 2 (R2) 11.41 11.37 11.41 11.41
Resistance 1 (R1) 11.35 11.34 11.32 11.34 11.40
Pivot Point 11.30 11.30 11.29 11.30 11.30
Support 1 (S1) 11.24 11.26 11.21 11.23 11.17
Support 2 (S2) 11.19 11.23 11.19 11.16
Support 3 (S3) 11.13 11.19 11.15
Support 4 (S4) 11.12